ArticleCardiology and therapy2016

A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.

Carme Pinyol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.